NCT05961774

Brief Summary

The goal of this clinical trial is to investigate mechanism underlying lumbar multifidus muscle (LM) activation deficits in adults with chronic low back pain (CLBP). The main questions it aim to answer is whether motor cortex or muscular level is the underlying mechanism responsible for the LM activation deficits. Participants will:

  • Undergo cortical excitability measurement using transcranial magnetic stimulation, LM activation measurement using ultrasound imaging, and force measurement using hand-held dynamometer.
  • Be randomly assigned to either repetitive magnetic stimulation (rTMS) or neuromuscular electrical stimulation (NMES)
  • Undergo all measurement at post-intervention Researchers will compare within and between groups to see changes in cortical excitability, LM activation, and force.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2024

Completed
Last Updated

June 18, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

July 13, 2023

Last Update Submit

June 17, 2024

Conditions

Keywords

Low back painTranscranial magnetic stimulationNeuromuscular electrical stimulationCortical excitabilityMuscle activation

Outcome Measures

Primary Outcomes (7)

  • Resting motor threshold

    The stimulus intensity that causes a minimum motor response in a resting muscle during single transcranial magnetic stimulation (TMS) pulses applied over the motor hotspot.

    Change from baseline after 1 session

  • Active motor threshold

    The lowest stimulus intensity to elicit a motor evoked potential ≥ 200μV in 5 out of 10 consecutive trials during an isometric contraction of 10% maximum voluntary contraction in the target muscle.

    Change from baseline after 1 session

  • Motor evoked potential

    The electrical signals recorded from the descending motor pathways or from muscles following stimulation of motor pathways within the brain.

    Change from baseline after 1 session

  • Cortical silent period

    The temporary interruption of electromyographic signal from a muscle following a motor evoked potential triggered by transcranial magnetic stimulation over the primary motor cortex.

    Change from baseline after 1 session

  • Muscle thickness

    Muscle contractility.

    Change from baseline after 1 session

  • Muscle cross-sectional area

    Cross-sectional area can be related to joint torque production and isokinetic strength in different muscle groups.

    Change from baseline after 1 session

  • Muscle pennation angle

    Pennation angle can represent the maximum force developed by a muscle

    Change from baseline after 1 session

Secondary Outcomes (1)

  • Force generation

    Change from baseline after 1 session

Study Arms (2)

High frequency repetitive transcranial magnetic stimulation

EXPERIMENTAL

This group will receive high frequency repetitive transcranial magnetic stimulation.

Device: Transcranial magnetic stimulation

Neuromuscular electrical stimulation

ACTIVE COMPARATOR

This group will receive neuromuscular electrical stimulation.

Device: Neuromuscular electrical stimulation

Interventions

The stimulation point is the lumbar multifidus hotspot. The parameters will be set at frequency 10 Hz, 50 number of pulses, 40 train of stimulation (5 seconds stimulation and 25 seconds inter-stimulation interval). The position of coil will be placed tangentially at 45 degrees on the LM hotspot. The stimulation will be 20 minutes.

High frequency repetitive transcranial magnetic stimulation

The neuromuscular electrical stimulation will be set as interferential current 6000 Hz, amplitude 20-50 Hz with scanning mode, duration 20 minutes, intensity to elicit the LM contraction.

Neuromuscular electrical stimulation

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female age between 18 and 40 years.
  • Experience of low back pain at least 3 months, or recurrent of back pain for at least two episodes in 6 months that interferes with activities of daily living.

You may not qualify if:

  • Spondylolysis, spondylolisthesis, spine tumor and malignancy
  • Radiculopathy or myelopathy
  • History of lumbar or abdominal surgery
  • Pregnancy
  • Neurological Disease (e.g., stroke, Parkinson, traumatic brain injury, spinal cord injury)
  • Major cardiovascular diseases (e.g., heart failure, coronary artery diseases, angina pain)
  • Skin lesion (e.g., skin laceration) on site of stimulation.
  • Experience of lumbar motor control exercise more than or equal to 2 weeks
  • Metal implantation sensitive to magnetic field, or cardiac implantations
  • BMI greater or equal to 30 kg/m2
  • Taking any medications that would interfere with brain stimulation (e.g., Calcium channel blockers, Na+ channel blocker, NMDA antagonist, Glutamate receptor antagonist, nicotine uptake)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Mahidol University

Salaya, Changwat Nakhon Pathom, 73170, Thailand

Location

Related Publications (12)

  • Songjaroen S, Sungnak P, Piriyaprasarth P, Wang HK, Laskin JJ, Wattananon P. Combined neuromuscular electrical stimulation with motor control exercise can improve lumbar multifidus activation in individuals with recurrent low back pain. Sci Rep. 2021 Jul 20;11(1):14815. doi: 10.1038/s41598-021-94402-2.

    PMID: 34285318BACKGROUND
  • Wattananon P, Sungnak P, Songjaroen S, Kantha P, Hsu WL, Wang HK. Using neuromuscular electrical stimulation in conjunction with ultrasound imaging technique to investigate lumbar multifidus muscle activation deficit. Musculoskelet Sci Pract. 2020 Dec;50:102215. doi: 10.1016/j.msksp.2020.102215. Epub 2020 Jul 13.

    PMID: 33220931BACKGROUND
  • Hodges PW, Danneels L. Changes in Structure and Function of the Back Muscles in Low Back Pain: Different Time Points, Observations, and Mechanisms. J Orthop Sports Phys Ther. 2019 Jun;49(6):464-476. doi: 10.2519/jospt.2019.8827.

    PMID: 31151377BACKGROUND
  • Wallwork TL, Stanton WR, Freke M, Hides JA. The effect of chronic low back pain on size and contraction of the lumbar multifidus muscle. Man Ther. 2009 Oct;14(5):496-500. doi: 10.1016/j.math.2008.09.006. Epub 2008 Nov 21.

    PMID: 19027343BACKGROUND
  • Tsao H, Danneels LA, Hodges PW. ISSLS prize winner: Smudging the motor brain in young adults with recurrent low back pain. Spine (Phila Pa 1976). 2011 Oct 1;36(21):1721-7. doi: 10.1097/BRS.0b013e31821c4267.

    PMID: 21508892BACKGROUND
  • Wand BM, Parkitny L, O'Connell NE, Luomajoki H, McAuley JH, Thacker M, Moseley GL. Cortical changes in chronic low back pain: current state of the art and implications for clinical practice. Man Ther. 2011 Feb;16(1):15-20. doi: 10.1016/j.math.2010.06.008. Epub 2010 Jul 23.

    PMID: 20655796BACKGROUND
  • Masse-Alarie H, Beaulieu LD, Preuss R, Schneider C. Corticomotor control of lumbar multifidus muscles is impaired in chronic low back pain: concurrent evidence from ultrasound imaging and double-pulse transcranial magnetic stimulation. Exp Brain Res. 2016 Apr;234(4):1033-45. doi: 10.1007/s00221-015-4528-x. Epub 2015 Dec 26.

    PMID: 26708518BACKGROUND
  • van Dieen JH, Reeves NP, Kawchuk G, van Dillen LR, Hodges PW. Motor Control Changes in Low Back Pain: Divergence in Presentations and Mechanisms. J Orthop Sports Phys Ther. 2019 Jun;49(6):370-379. doi: 10.2519/jospt.2019.7917. Epub 2018 Jun 12.

    PMID: 29895230BACKGROUND
  • Strutton PH, Theodorou S, Catley M, McGregor AH, Davey NJ. Corticospinal excitability in patients with chronic low back pain. J Spinal Disord Tech. 2005 Oct;18(5):420-4. doi: 10.1097/01.bsd.0000169063.84628.fe.

    PMID: 16189454BACKGROUND
  • Masse-Alarie H, Beaulieu LD, Preuss R, Schneider C. The side of chronic low back pain matters: evidence from the primary motor cortex excitability and the postural adjustments of multifidi muscles. Exp Brain Res. 2017 Mar;235(3):647-659. doi: 10.1007/s00221-016-4834-y. Epub 2016 Nov 15.

    PMID: 27847987BACKGROUND
  • Patricio P, Roy JS, Macedo L, Roy M, Leonard G, Hodges P, Masse-Alarie H. Repetitive transcranial magnetic stimulation alone and in combination with motor control exercise for the treatment of individuals with chronic non-specific low back pain (ExTraStim trial): study protocol for a randomised controlled trial. BMJ Open. 2021 Mar 24;11(3):e045504. doi: 10.1136/bmjopen-2020-045504.

    PMID: 33762244BACKGROUND
  • O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2014 Apr 11;(4):CD008208. doi: 10.1002/14651858.CD008208.pub3.

    PMID: 24729198BACKGROUND

MeSH Terms

Conditions

Low Back Pain

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Peemongkon Wattananon, PhD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 13, 2023

First Posted

July 27, 2023

Study Start

March 15, 2023

Primary Completion

March 14, 2024

Study Completion

June 14, 2024

Last Updated

June 18, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Unidentifiable data can be shared upon request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After June 2023 for 5 years.
Access Criteria
Written request will be reviewed by principal investigator.

Locations